ALCON LABORATORIES, INC. for ALCON LABORATORIES INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues regarding drug safety, track & trace & pedigree.
Foreign entity interest: From January 1, 2011 to April 7, 2011, Novartis AG, a foreign Swiss entity, was the majority shareholder of Alcon, Inc. On April 8, 2011, Novartis AG became the sole shareholder of Alcon, Inc. and Alcon, Inc. was merged out of corporate existence. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. was a subsidiary of Alcon, Inc. until April 7, 2011. On April 8, 2011, with the dissolution of Alcon, Inc., Alcon Holdings, Inc. became a subsidiary of Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Taxation/Internal Revenue Code TAX
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Foreign entity interest: From January 1, 2011 to April 7, 2011, Novartis AG, a foreign Swiss entity, was the majority shareholder of Alcon, Inc. On April 8, 2011, Novartis AG became the sole shareholder of Alcon, Inc. and Alcon, Inc. was merged out of corporate existence. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. was a subsidiary of Alcon, Inc. until April 7, 2011. On April 8, 2011, with the dissolution of Alcon, Inc., Alcon Holdings, Inc. became a subsidiary of Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Medicare/Medicaid MMM
Issues concerning the NTIOL program.
Foreign entity interest: From January 1, 2011 to April 7, 2011, Novartis AG, a foreign Swiss entity, was the majority shareholder of Alcon, Inc. On April 8, 2011, Novartis AG became the sole shareholder of Alcon, Inc. and Alcon, Inc. was merged out of corporate existence. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. was a subsidiary of Alcon, Inc. until April 7, 2011. On April 8, 2011, with the dissolution of Alcon, Inc., Alcon Holdings, Inc. became a subsidiary of Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVARTIS INTERNATIONAL AG | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.